35 New Sites Chosen for CMMI Community-Based Care Transitions Program
Tuesday, January 22, 2013
by: VNAA Policy Team

Section: Public Policy and Advocacy




On January 15, the Center for Medicare and Medicaid Innovation (CMMI) announced 35 new participants in the Community-based Care Transitions program (CCTP). In August, 17 partners were chosen bringing the total number of sites in the program to 82. The new participants will be across 24 states and CMS hopes  to provide care transitions to nearly 500,000 Medicare beneficiaries across 33 states with this initiative. To review the 35 new participants click here.

CMMI will continue to accept applications for new sites and approve participants on a rolling basis, based on funding. The statute defines an eligible entity as an acute care hospital or an appropriate Community-Based Organization (CBO). An eligible CBO is one that is: (1) a legal entity, such as a 501(c)(3) organization or other organization that has a taxpayer identification number and can accept payment, (2) has a governing body that includes broad community representation of multiple health care stakeholders, including more specific requirements regarding consumers board members and (3) is physically located in the community it proposes to serve. Each site will sign a two-year agreement with CMS with the option to renew for the rest of the program’s five year commitment based on the sites success. The program can spend up to $500 million over that five year period.

To review the program materials and learn more about applying for this opportunity, please visit the CMMI Website here.  

This program was created by Section 3026 of the Affordable Care Act to test models for improving care transitions from the hospice to other care setting including the home. In addition to transitions, the program will test models for reducing readmissions for high-risk Medicare patients and improved care quality. As with many programs in CMMI, they are looking for measurable savings for the Medicare program in addition to positive clinical outcomes.
Post a Comment

Name
Email
Comment